6:04 AM ET
8-K
Other 8-K Filing
DBV Technologies Other 8-K Filing
DBV Technologies has submitted a Biologics License Application (BLA) to the U.S. FDA for its VIASKIN Peanut Patch for children aged 4-7 years. The submission is based on positive Phase 3 VITESSE trial results and marks the company's transition toward a commercial-stage organization. The company has requested Priority Review for the application.
- Counterparty
- FDA